只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-29 2026-07-31 | NP Neptune Insurance Holdings Inc. | FTV VII, L.P. TenPercentOwner | 卖出(S) | 1,867,840 | US$33.22 | US$6204.96万 | 14,442,941 | SEC |
| 2026-07-29 2026-07-31 | NP Neptune Insurance Holdings Inc. | FTV NE-Aggregator, LLC TenPercentOwner | 卖出(S) | 1,867,840 | US$33.22 | US$6204.96万 | 14,442,941 | SEC |
| 2026-07-29 2026-07-31 | NP Neptune Insurance Holdings Inc. | FTV Management VII, L.P. TenPercentOwner | 卖出(S) | 1,867,840 | US$33.22 | US$6204.96万 | 14,442,941 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-26 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 3,727 | US$8.88 | US$33,095.76 | 924,960 | SEC |
| 2026-06-25 2026-06-26 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 3,727 | US$8.88 | US$33,095.76 | 924,960 | SEC |
| 2026-06-24 2026-06-26 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 4,047 | US$8.66 | US$35,047.02 | 921,233 | SEC |
| 2026-06-24 2026-06-26 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 4,047 | US$8.66 | US$35,047.02 | 921,233 | SEC |
| 2026-06-23 2026-06-24 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 34,596 | US$8.68 | US$300,293.28 | 917,186 | SEC |
| 2026-06-23 2026-06-24 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 34,596 | US$8.68 | US$300,293.28 | 917,186 | SEC |
| 2026-06-22 2026-06-24 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 20,968 | US$8.65 | US$181,373.20 | 882,590 | SEC |
| 2026-06-22 2026-06-24 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 20,968 | US$8.65 | US$181,373.20 | 882,590 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-15 2026-06-26 | STVN Stevanato Group S.p.A. | FEDERICI WILLIAM J Director | 卖出(S) | 1,493 | US$17.09 | US$25,515.37 | 26,991 | SEC |
| 2026-06-15 2026-06-26 | STVN Stevanato Group S.p.A. | Flynn Karen Director | 卖出(S) | 1,493 | US$17.09 | US$25,515.37 | 5,757 | SEC |
| 2026-06-15 2026-06-26 | STVN Stevanato Group S.p.A. | MOREL DONALD E JR Director | 卖出(S) | 1,493 | US$17.09 | US$25,515.37 | 37,424 | SEC |
| 2026-06-15 2026-06-26 | STVN Stevanato Group S.p.A. | Balachandran Madhavan Director | 卖出(S) | 1,493 | US$17.09 | US$25,515.37 | 69,458 | SEC |
| 2026-06-15 2026-06-16 | APTV Aptiv PLC | Louissaint Obed D. Officer · EVP & Chief People Officer | 卖出(S) | 3,000 | US$69.60 | US$208,800.00 | 210,803 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | TVTX Travere Therapeutics, Inc. | Coughlin Timothy Director | 卖出(S) | 10,000 | US$50.07 | US$500,700.00 | 56,250 | SEC |
| 2026-06-12 2026-06-16 | TVTX Travere Therapeutics, Inc. | Baynes Roy D. Director | 卖出(S) | 4,500 | US$50.00 | US$225,000.00 | 41,500 | SEC |
| 2026-06-11 2026-06-12 | FUBO FuboTV Inc. | Horihuela Alberto Officer · Chief Operating Officer | 卖出(S) | 141,074 | US$10.38 | US$146.43万 | 0 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-09 2026-06-11 | PETV PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC TenPercentOwner | 买入(P) | 187,500 | US$0.00 | US$0.00 | 10,439,729 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-03 2026-06-05 | CMTV COMMUNITY BANCORP /VT | Martin Carol Director | 买入(P) | 72 | US$36.00 | US$2,592.00 | 10,491.72 | SEC |
| 2026-06-03 2026-06-04 | APTV Aptiv PLC | Ramundo Katherine H Officer · EVP, CLO, CCO & Secretary | 卖出(S) | 2,000 | US$78.30 | US$156,600.00 | 163,752 | SEC |
| 2026-06-02 2026-06-04 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 5,748 | US$10.52 | US$60,468.96 | 861,622 | SEC |
| 2026-06-02 2026-06-04 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 5,748 | US$10.52 | US$60,468.96 | 861,622 | SEC |
| 2026-06-01 2026-06-02 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 4,642 | US$10.43 | US$48,416.06 | 855,874 | SEC |
| 2026-06-01 2026-06-02 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 4,642 | US$10.43 | US$48,416.06 | 855,874 | SEC |
| 2026-05-29 2026-06-02 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 9,297 | US$10.37 | US$96,409.89 | 851,232 | SEC |
| 2026-05-29 2026-06-02 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 9,297 | US$10.37 | US$96,409.89 | 851,232 | SEC |
| 2026-05-28 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 26,666 | US$31.36 | US$836,245.76 | 307,056 | SEC |
| 2026-05-28 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 4,415 | US$30.29 | US$133,730.35 | 333,722 | SEC |
| 2026-05-27 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 76,510 | US$29.72 | US$227.39万 | 368,327 | SEC |
| 2026-05-27 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 30,190 | US$30.63 | US$924,719.70 | 338,137 | SEC |
| 2026-05-27 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 17,481 | US$30.14 | US$526,877.34 | 26,278 | SEC |
| 2026-05-27 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 3,978 | US$30.88 | US$122,840.64 | 22,300 | SEC |
| 2026-05-26 2026-05-28 | TV GRUPO TELEVISA, S.A.B. | ENRIQUEZ DAHLHAUS Jean Michel Director | 卖出(S) | 116,500 | US$0.57 | US$66,405.00 | 116,500 | SEC |
| 2026-05-26 2026-05-28 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 23,386 | US$10.88 | US$254,439.68 | 841,935 | SEC |
| 2026-05-26 2026-05-28 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 23,386 | US$10.88 | US$254,439.68 | 841,935 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 6,924 | US$31.25 | US$216,375.00 | 4,600 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 3,606 | US$30.43 | US$109,730.58 | 63,994 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 20,235 | US$31.24 | US$632,141.40 | 43,759 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 3,676 | US$30.42 | US$111,823.92 | 11,524 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 10,611 | US$30.40 | US$322,574.40 | 504,445 | SEC |
| 2026-05-26 2026-05-28 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 59,608 | US$31.24 | US$186.22万 | 444,837 | SEC |
| 2026-05-26 2026-05-27 | TV GRUPO TELEVISA, S.A.B. | FOLCH VIADERO Salvi Rafael Director | 卖出(S) | 32,997 | US$0.56 | US$18,478.32 | 0 | SEC |
| 2026-05-25 2026-05-27 | TV GRUPO TELEVISA, S.A.B. | FOLCH VIADERO Salvi Rafael Director | 卖出(S) | 200,003 | US$0.56 | US$112,001.68 | 32,997 | SEC |
| 2026-05-22 2026-05-26 | PETV PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC TenPercentOwner | 买入(P) | 250,000 | US$0.40 | US$100,000.00 | 10,452,229 | SEC |
| 2026-05-20 2026-05-22 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 18,902 | US$10.87 | US$205,464.74 | 818,549 | SEC |
| 2026-05-20 2026-05-22 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 18,902 | US$10.87 | US$205,464.74 | 818,549 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II SES Investment, LLC TenPercentOwner | 卖出(S) | 617,240 | US$18.92 | US$1167.82万 | 2,615,972 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II SES Investment B, LLC TenPercentOwner | 卖出(S) | 617,240 | US$18.92 | US$1167.82万 | 2,615,972 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II GP, L.P. TenPercentOwner | 卖出(S) | 617,240 | US$18.92 | US$1167.82万 | 2,615,972 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II SES Investment, LLC TenPercentOwner | 卖出(S) | 2,632,760 | US$18.92 | US$4981.18万 | 0 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II SES Investment B, LLC TenPercentOwner | 卖出(S) | 2,632,760 | US$18.92 | US$4981.18万 | 0 | SEC |
| 2026-05-19 2026-05-21 | WTTR Select Water Solutions, Inc. | Crestview Partners II GP, L.P. TenPercentOwner | 卖出(S) | 2,632,760 | US$18.92 | US$4981.18万 | 0 | SEC |
| 2026-05-19 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV NE-Aggregator, LLC TenPercentOwner | 卖出(S) | 787,806 | US$26.40 | US$2079.81万 | 16,310,781 | SEC |
| 2026-05-19 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV Management VII, L.P. TenPercentOwner | 卖出(S) | 787,806 | US$26.40 | US$2079.81万 | 16,310,781 | SEC |
| 2026-05-19 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV VII, L.P. TenPercentOwner | 卖出(S) | 787,806 | US$26.40 | US$2079.81万 | 16,310,781 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Aslan Fred Director,Officer · Chief Executive Officer | 卖出(S) | 27,116 | US$9.01 | US$244,315.16 | 1,535,082 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Banerjee Subhashis Officer · Chief Medical Officer | 卖出(S) | 7,037 | US$9.01 | US$63,403.37 | 144,963 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Bush Jennifer Officer · COO, CLO, Compliance Officer | 卖出(S) | 8,790 | US$9.01 | US$79,197.90 | 337,920 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Horan Christopher Officer · Chief Tech Operations Officer | 卖出(S) | 7,002 | US$9.01 | US$63,088.02 | 293,450 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Raymon Heather Officer · SVP, Research and Development | 卖出(S) | 3,095 | US$9.01 | US$27,885.95 | 148,228 | SEC |
| 2026-05-18 2026-05-18 | VIDA VIDA Global Inc. | TVP Bitcoin Venture GP I, L.L.C. TenPercentOwner | 买入(P) | 375,000 | US$4.00 | US$150万 | 2,011,046 | SEC |
| 2026-05-18 2026-05-18 | VIDA VIDA Global Inc. | TVP Bitcoin Venture Fund II, L.P. TenPercentOwner | 买入(P) | 375,000 | US$4.00 | US$150万 | 2,011,046 | SEC |
| 2026-05-18 2026-05-18 | VIDA VIDA Global Inc. | TVP Bitcoin Venture GP II, L.L.C. TenPercentOwner | 买入(P) | 375,000 | US$4.00 | US$150万 | 2,011,046 | SEC |
| 2026-05-18 2026-05-18 | VIDA VIDA Global Inc. | TVP Bitcoin Venture Fund I, L.P. TenPercentOwner | 买入(P) | 375,000 | US$4.00 | US$150万 | 2,011,046 | SEC |
| 2026-05-15 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV NE-Aggregator, LLC TenPercentOwner | 卖出(S) | 5,252,044 | US$26.40 | US$1.39亿 | 17,098,587 | SEC |
| 2026-05-15 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV Management VII, L.P. TenPercentOwner | 卖出(S) | 5,252,044 | US$26.40 | US$1.39亿 | 17,098,587 | SEC |
| 2026-05-15 2026-05-19 | NP Neptune Insurance Holdings Inc. | FTV VII, L.P. TenPercentOwner | 卖出(S) | 5,252,044 | US$26.40 | US$1.39亿 | 17,098,587 | SEC |
| 2026-05-15 2026-05-19 | TVTX Travere Therapeutics, Inc. | Coughlin Timothy Director | 卖出(S) | 3,250 | US$43.49 | US$141,342.50 | 52,250 | SEC |
| 2026-05-14 2026-05-18 | GEV GE Vernova Inc. | Potvin Matthew Joseph Officer · Chief Accounting Officer | 卖出(S) | 2,333 | US$1,059.09 | US$247.09万 | 3,549 | SEC |
| 2026-05-13 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 5,351 | US$27.17 | US$145,386.67 | 67,600 | SEC |
| 2026-05-13 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 89,107 | US$27.48 | US$244.87万 | 516,226 | SEC |
| 2026-05-13 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 1,170 | US$27.83 | US$32,561.10 | 515,056 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 116,723 | US$28.57 | US$333.48万 | 606,333 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 1,000 | US$29.17 | US$29,170.00 | 605,333 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 10,500 | US$28.72 | US$301,560.00 | 15,300 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 100 | US$29.29 | US$2,929.00 | 15,200 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 39,649 | US$28.57 | US$113.28万 | 73,251 | SEC |
| 2026-05-12 2026-05-14 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTVE OFFICER | 卖出(S) | 300 | US$29.23 | US$8,769.00 | 72,951 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Corp. TenPercentOwner | 买入(P) | 1,085,069 | US$11.52 | US$1250万 | 4,391,969 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Cell Corp TenPercentOwner | 买入(P) | 1,085,069 | US$11.52 | US$1250万 | 4,391,969 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Corp. TenPercentOwner | 买入(P) | 347,222 | US$11.52 | US$400万 | 1,607,734 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Cell Corp TenPercentOwner | 买入(P) | 347,222 | US$11.52 | US$400万 | 1,607,734 | SEC |
| 2026-05-11 2026-05-13 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest GP I, LLC TenPercentOwner | 买入(P) | 8,542 | US$10.61 | US$90,630.62 | 799,647 | SEC |
| 2026-05-11 2026-05-13 | CRT CROSS TIMBERS ROYALTY TRUST | SoftVest, LP TenPercentOwner | 买入(P) | 8,542 | US$10.61 | US$90,630.62 | 799,647 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入(P) | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| TVAI | 2 | 0 | 2 | 100.00% | Q |
| BSTV | 106 | 0 | 110.3586 | 96.05% | Q |
| TVIV | 72 | 0 | 75 | 96.00% | Q |
| CMTV | 2,340 | 31 | 2,689.9742 | 86.99% | Q, N |
| WTV | 112,196.6179 | 0 | 145,601.4903 | 77.06% | Q, N |
| CTVA | 3,257,746.8775 | 27,996.6458 | 4,461,949.3895 | 73.01% | B, Q, N |
| ARTV | 117,221.8532 | 1,900 | 160,953.9362 | 72.83% | B, Q, N |
| MATV | 106,482.0033 | 0 | 147,550.0019 | 72.17% | B, Q, N |
| ETV | 57,457.2437 | 1,700 | 88,779.7303 | 64.72% | Q, N |
| MTVA | 39,608 | 0 | 66,708.4598 | 59.37% | Q, N |
| VTVT | 18,535.2522 | 0 | 31,796.6603 | 58.29% | Q, N |
| TVTX | 434,969.8904 | 0 | 746,306.8063 | 58.28% | B, Q, N |
| FTV | 482,824.2063 | 1,113 | 901,879.4271 | 53.54% | B, Q, N |
| VTV | 728,592.2186 | 2,608 | 1,394,688.0099 | 52.24% | B, Q, N |
| METV | 3,991.7616 | 0 | 7,711.0153 | 51.77% | Q, N |
| TVGN | 2,497 | 0 | 5,078.0255 | 49.17% | Q, N |
| OCTV | 108,717 | 0 | 245,161.8841 | 44.34% | B, Q, N |
| TV | 94,667.2044 | 0 | 216,677.2002 | 43.69% | B, Q, N |
| STVN | 41,418 | 4 | 97,988.3551 | 42.27% | Q, N |
| PMTV | 9,930.8007 | 0 | 25,986.7738 | 38.21% | B, Q |
| APTV | 512,073.0005 | 106 | 1,398,161.0863 | 36.62% | B, Q, N |
| TVRD | 33,480.726 | 202 | 92,067.8732 | 36.37% | Q, N |
| PSTV | 13,196.271 | 0 | 40,657.563 | 32.46% | B, Q, N |
| TVAL | 11,332.1101 | 0 | 50,482.8091 | 22.45% | Q |
| TVC | 312 | 0 | 2,106.7781 | 14.81% | Q |
| TVGNW | 65,262 | 58,900 | 458,387 | 14.24% | Q |
| TVE | 30 | 0 | 861.1556 | 3.48% | Q |
| TVA | 101 | 0 | 6,143 | 1.64% | Q |